MX2022006278A - Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos. - Google Patents
Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos.Info
- Publication number
- MX2022006278A MX2022006278A MX2022006278A MX2022006278A MX2022006278A MX 2022006278 A MX2022006278 A MX 2022006278A MX 2022006278 A MX2022006278 A MX 2022006278A MX 2022006278 A MX2022006278 A MX 2022006278A MX 2022006278 A MX2022006278 A MX 2022006278A
- Authority
- MX
- Mexico
- Prior art keywords
- diagnosis
- prevention
- treatment
- malignant tumours
- salmon proteins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Se describen proteínas de salmón UK 114 para uso en el tratamiento, diagnóstico y prevención de tumores malignos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000022203A IT201900022203A1 (it) | 2019-11-26 | 2019-11-26 | Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne |
PCT/EP2020/083069 WO2021105059A1 (en) | 2019-11-26 | 2020-11-23 | Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022006278A true MX2022006278A (es) | 2022-08-15 |
Family
ID=70009105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022006278A MX2022006278A (es) | 2019-11-26 | 2020-11-23 | Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230000946A1 (es) |
EP (1) | EP4065154A1 (es) |
JP (1) | JP2023504241A (es) |
CN (1) | CN114761034A (es) |
CA (1) | CA3159292A1 (es) |
IT (1) | IT201900022203A1 (es) |
MX (1) | MX2022006278A (es) |
WO (1) | WO2021105059A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024189565A1 (en) * | 2023-03-14 | 2024-09-19 | Giovanni Bussolati | Reactive intermediate deaminase a (rida) for use in preventing and/or treating cachexia |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1270618B (it) | 1994-07-14 | 1997-05-07 | Zetesis Spa | Proteine ad attivita' antitumorale |
IT1276860B1 (it) * | 1994-11-04 | 1997-11-03 | Zetesis Spa | Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione |
US20010014471A1 (en) | 1999-04-15 | 2001-08-16 | Vytautas Naktinis | Recombinant protein and its use in therapy and diagnostics |
IT201600127428A1 (it) * | 2016-12-16 | 2018-06-16 | Cusani Alberto Bartorelli | Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne |
-
2019
- 2019-11-26 IT IT102019000022203A patent/IT201900022203A1/it unknown
-
2020
- 2020-11-23 MX MX2022006278A patent/MX2022006278A/es unknown
- 2020-11-23 JP JP2022530848A patent/JP2023504241A/ja active Pending
- 2020-11-23 CN CN202080081596.6A patent/CN114761034A/zh active Pending
- 2020-11-23 EP EP20820795.1A patent/EP4065154A1/en active Pending
- 2020-11-23 WO PCT/EP2020/083069 patent/WO2021105059A1/en unknown
- 2020-11-23 CA CA3159292A patent/CA3159292A1/en active Pending
- 2020-11-23 US US17/756,262 patent/US20230000946A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021105059A1 (en) | 2021-06-03 |
EP4065154A1 (en) | 2022-10-05 |
JP2023504241A (ja) | 2023-02-02 |
IT201900022203A1 (it) | 2021-05-26 |
US20230000946A1 (en) | 2023-01-05 |
CA3159292A1 (en) | 2021-06-03 |
CN114761034A (zh) | 2022-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020551923A1 (en) | Methods and compositions for treating cancer | |
GEP20237458B (en) | Combination product of bcl-2 inhibitor and mdm2 inhibitor and use thereof in the prevention and/or treatment of diseases | |
PH12021550152A1 (en) | Anti-cd112r compositions and methods | |
WO2017096309A8 (en) | Methods of treatment of malignancies | |
MX2017014532A (es) | Vacunas para el tratamiento y prevencion del cancer. | |
MX2019011148A (es) | Metodos de tratamiento. | |
PH12021551036A1 (en) | Anti-liv1 immune cell cancer therapy | |
MX2022007994A (es) | Derivados de arilciclohexilamina y su uso en el tratamiento de trastornos psiquiátricos. | |
PH12019502197A1 (en) | Macrocyclic compound and uses thereof | |
MX2020009733A (es) | Composiciones. | |
AU2016304856A8 (en) | Mechanism of resistance to BET bromodomain inhibitors | |
PH12021551047A1 (en) | Anti-ptk7 immune cell cancer therapy | |
MX2019015676A (es) | Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento. | |
MX2022005563A (es) | Ligandos de la pseudoquinasa tyk2. | |
MX2021008834A (es) | Metodos de tratamiento del cancer de mama con tucatinib. | |
HK1116186A1 (en) | Azaxanthones and use thereof for treating tumors | |
MX2020009532A (es) | Oligonucleotidos modificados para uso en el tratamiento de tauopatias. | |
MX2022005358A (es) | Composiciones de copolímero de bloque sensibles al ph, micelas, y métodos de uso. | |
PH12021550122A1 (en) | Solubilized apyrases, methods and use | |
MX2021003262A (es) | Metodos de tratamiento. | |
MX2020013103A (es) | Metodos de uso de cd24 para la prevencion y tratamiento de recaida de leucemia. | |
PH12021550121A1 (en) | Methods of treating hfpef employing dapagliflozin and compositions comprising the same | |
MX2022006278A (es) | Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos. | |
MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2020000636A (es) | Proteinas sinteticas y usos terapeuticos de las mismas. |